[Tracheomalacia (TM) or bronchomalacia (BM) in children: conservative or invasive therapy]

Arch Pediatr. 2010 Jan;17(1):97-104. doi: 10.1016/j.arcped.2009.09.015. Epub 2009 Nov 4.
[Article in French]


Tracheomalacia (TM) or bronchomalacia (BM) refers to softness or weakness of the trachea or the bronchi. Its management is not evidenced-based. Conservative therapy is preferred in milder cases, since the outcome is usually favourable within the first 2 years of life. The clinical utility of non-specific treatments (anti-inflammatory agents, bronchodilators, antibiotics, physiotherapy) has not been proven by clinical trials. Treatment of symptomatic cases should be discussed on an individual basis. Airway surgery should be avoided, and non-invasive ventilation may be proposed as a temporary measure. In case of very severe cases, aortopexy, trachostomy or stent placement are the preferred treatments. Regular respiratory monitoring until remission is mandatory.

Publication types

  • English Abstract

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Aorta, Thoracic / surgery
  • Bronchodilator Agents / administration & dosage
  • Bronchomalacia / diagnosis
  • Bronchomalacia / therapy*
  • Combined Modality Therapy
  • Evidence-Based Medicine
  • Humans
  • Infant
  • Infant, Newborn
  • Physical Therapy Modalities
  • Prognosis
  • Stents
  • Sutures
  • Tracheomalacia / diagnosis
  • Tracheomalacia / therapy*
  • Tracheostomy


  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Bronchodilator Agents